| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on February 13, 2002
Revised on June 6, 2002
Accepted on June 6, 2002
i2 Expression in Cultured Atrial Cells
From the Cardiovascular Division (H.-J.P., U.B., D.K., H.Y., J.B.G.), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass; the Department of Molecular Biology and Biochemistry (T.F.O.), University of California-Irvine, Irvine, Calif; and the Department of Biochemistry and Molecular Pharmacology (L.Y., F.B.H.), School of Medicine, West Virginia University, Morgantown, WV.
* To whom correspondence should be addressed. E-mail: Galper{at}calvin.bwh.harvard.edu.
We have previously demonstrated that growth of embryonic chick atrial cells in medium supplemented with lipoprotein-depleted serum (LPDS) resulted in a coordinate increase in the expression of genes involved in the parasympathetic response of the heart (the M2 muscarinic receptor; the
-subunit of the heterotrimeric G protein, G
i2; and the inward rectifying K+ channel protein, GIRK1) and a marked increase in the negative chronotropic response of atrial cells to muscarinic stimulation. In the present study, we demonstrate that regulation of G
i2 promoter activity by LPDS is mediated by the binding of a sterol regulatory element binding protein (SREBP) to a sterol regulatory element (SRE) in the G
i2 promoter. Deletion and point mutation of this putative SRE interfered with the regulation of the G
i2 promoter by SREBP and LPDS. Furthermore gel shift assays demonstrated that point mutations in the putative G
i2 SRE markedly inhibited the binding of purified SREBP to oligonucleotides containing the G
i2 SRE sequence. The expression of a dominant-negative SREBP mutant interfered with LPDS stimulation of G
i2 promoter activity. Finally, we demonstrate that SREBP-1 is markedly more potent than SREBP-2 for the stimulation of G
i2 promoter activity, suggesting that SREBP1 may play a role in the regulation of G
i2 expression. These are the first data to demonstrate SREBP regulation of a protein not involved in lipid homeostasis and suggest a new relationship between lipid metabolism and the parasympathetic response of the heart.
i2
This article has been cited by other articles:
![]() |
H.-J. Park, Y. Zhang, C. Du, C. M. Welzig, C. Madias, M. J. Aronovitz, S. P. Georgescu, I. Naggar, B. Wang, Y.-B. Kim, et al. Role of SREBP-1 in the Development of Parasympathetic Dysfunction in the Hearts of Type 1 Diabetic Akita Mice Circ. Res., July 31, 2009; 105(3): 287 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zuberi, L. Birnbaumer, and A. Tinker The role of inhibitory heterotrimeric G proteins in the control of in vivo heart rate dynamics Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1822 - R1830. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |